These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 29250665

  • 1. The correlation between insulin-like growth factor with glycemic control, glomerular filtration rate, blood pressure, hematological changes or body mass index in patients with type 2 diabetes mellitus.
    NeamŢu MC, Avramescu ET, Marcu IR, Turcu-Ştiolică A, Boldeanu MV, NeamŢu OM, Tudorache Ş, Dănciulescu Miulescu RE.
    Rom J Morphol Embryol; 2017; 58(3):857-861. PubMed ID: 29250665
    [Abstract] [Full Text] [Related]

  • 2. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
    Janssen JA, Jacobs ML, Derkx FH, Weber RF, van der Lely AJ, Lamberts SW.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
    López-Bermejo A, Khosravi J, Fernández-Real JM, Hwa V, Pratt KL, Casamitjana R, Garcia-Gil MM, Rosenfeld RG, Ricart W.
    Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.
    Drogan D, Schulze MB, Boeing H, Pischon T.
    Am J Epidemiol; 2016 Mar 15; 183(6):553-60. PubMed ID: 26880678
    [Abstract] [Full Text] [Related]

  • 9. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA, Maki KC, Unterman TG.
    J Clin Endocrinol Metab; 1997 May 15; 82(5):1484-91. PubMed ID: 9141538
    [Abstract] [Full Text] [Related]

  • 10. Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.
    Wu MK, Huang CY, Liou YJ, Wang CK, Lee SD.
    Int J Obes (Lond); 2008 Mar 15; 32(3):436-42. PubMed ID: 17955031
    [Abstract] [Full Text] [Related]

  • 11. Changes in insulin-like growth factor (IGF)-binding proteins after IGF-I injections in noninsulin-dependent diabetics.
    Young SC, Clemmons DR.
    J Clin Endocrinol Metab; 1994 Mar 15; 78(3):609-14. PubMed ID: 7510305
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decreased Serum IGF-1/IGFBP-3 Molar Ratio is Associated with Executive Function Behaviors in Type 2 Diabetic Patients with Mild Cognitive Impairment.
    Huang R, Wang P, Han J, Xia W, Cai R, Sun H, Sun J, Wang S.
    J Alzheimers Dis; 2015 Mar 15; 47(1):85-94. PubMed ID: 26402757
    [Abstract] [Full Text] [Related]

  • 14. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function.
    Paolisso G, Ammendola S, Del Buono A, Gambardella A, Riondino M, Tagliamonte MR, Rizzo MR, Carella C, Varricchio M.
    J Clin Endocrinol Metab; 1997 Jul 15; 82(7):2204-9. PubMed ID: 9215295
    [Abstract] [Full Text] [Related]

  • 15. Effect of a high-protein diet on ghrelin, growth hormone, and insulin-like growth factor-I and binding proteins 1 and 3 in subjects with type 2 diabetes mellitus.
    Gannon MC, Nuttall FQ.
    Metabolism; 2011 Sep 15; 60(9):1300-11. PubMed ID: 21406307
    [Abstract] [Full Text] [Related]

  • 16. The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease.
    Kucukhuseyin O, Toptas B, Timirci-Kahraman O, Isbir S, Karsidag K, Isbir T.
    In Vivo; 2015 Sep 15; 29(3):371-8. PubMed ID: 25977383
    [Abstract] [Full Text] [Related]

  • 17. Changes in insulin-like growth factor-I and its binding proteins are associated with diabetes mellitus in older adults.
    Aneke-Nash CS, Parrinello CM, Rajpathak SN, Rohan TE, Strotmeyer ES, Kritchevsky SB, Psaty BM, Bůžková P, Kizer JR, Newman AB, Strickler HD, Kaplan RC.
    J Am Geriatr Soc; 2015 May 15; 63(5):902-9. PubMed ID: 25989565
    [Abstract] [Full Text] [Related]

  • 18. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
    Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J.
    J Clin Endocrinol Metab; 2000 Apr 15; 85(4):1518-24. PubMed ID: 10770191
    [Abstract] [Full Text] [Related]

  • 19. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.
    Kajantie E, Fall CH, Seppälä M, Koistinen R, Dunkel L, Ylihärsilä H, Osmond C, Andersson S, Barker DJ, Forsén T, Holt RI, Phillips DI, Eriksson J.
    J Clin Endocrinol Metab; 2003 Mar 15; 88(3):1059-65. PubMed ID: 12629086
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.